Discover our IDF 2025 Partners
The IDF World Diabetes Congress 2025 is proud to have the participation and support of the following companies and organisations.
IDF 2025 Exhibition
Join us at the IDF 2025 Exhibition held in the Bangkok International Trade and Exhibition Center BITEC in Hall 98. Visit hands-on exhibition stands offering the chance to learn about exciting developments in diabetes technology and try out new devices.
Discover the grassroots work of 100 national diabetes associations in the IDF Global Village
Get unique hands-on experience and insights at our Industry partner stands
Meet the IDF Team at our stand in the heart of the global village
Forget about the old congress sandwich: Enjoy our delicious Thai lunch box
Chat and mingle with peers while charging your device
Print your personal CME Certificate
Get inspired by the Diabetes Spotlight and take part in campfire sessions on the IDF Stand
Don’t miss our digital poster area and learn about the findings of highly rated abstract authors at one of our nine E-Poster stations
Satellite symposia
Satellite symposia offer invaluable insights into the latest advancements in diabetes care and research.
Attendees gain direct access to emerging therapies, technologies, and solutions that can enhance patient outcomes, making these symposia an essential addition to the Congress experience.
Meet our partners and supporters
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.
Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next generation preventive healthcare solutions. We create evidence-based, personalised health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring. To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension.
The Almond Board of Australia is the peak body representing Australia's almond growers, processors, and marketers. We promote the major Australian almond exporters and communicate the key attributes of Australian almonds, which are rich in protein, fibre, healthy fats, Vitamin E, and Magnesium.
Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. We created the world-renowned CONTOUR® portfolio of blood glucose monitoring systems and are the exclusive global distribution partner for the Eversense® CGM Systems. These products combine advanced technology with user-friendly functionality to help people with diabetes manage their condition and make a positive difference to their lives.
AstraZeneca, a leading science-led biopharmaceutical company with over 40 years history in Thailand. The company is committed to creating life-changing innovative medicines and improving access to the Thai community. We are dedicated to improving patient outcomes and transforming the future of healthcare by harnessing the power of science to build a healthy future for Thai people, society and the planet. AstraZeneca Thailand's therapy area covers Cardiovascular, Renal and metabolism (CVRM), Respiratory, Immunology, Vaccines, and Immune Therapies (RIVIT), Oncology, and Rare Disease. With more than 350 highly qualified employees and over 20 medicines in the company portfolio. AstraZeneca focuses on delivering the greatest benefits to patients, healthcare systems, and societies.
AusMed Global is a fast-growing life sciences company at the forefront of non-invasive ketone technologies designed to combat diabetes, obesity, and beyond. Our solutions include hardware, software, and API connectivity options. We offer both B2B and B2B2C models, providing critical, easy-to-use, personalized analysis for point-of-care and home use, with the potential for seamless integration into healthcare and insurance systems. KetoMetrics ketone technologies support emerging evidence-based ketone therapies for a range of conditions, including cardiovascular diseases, certain types of cancer, Alzheimer’s disease, bipolar disorder, concussion, non-alcoholic fatty liver disease (NAFLD), in-vitro fertilization (IVF), ketone supplementation, sports science, and PET imaging. We are excited to collaborate with global partners to transform diabetes care, promote holistic health, and ultimately support healthy longevity for individuals worldwide.
#dedoc° runs the world’s largest scholarship program for diabetes advocates. Every year, we empower hundreds of #dedoc° voices to attend ATTD, EASD and ISPAD as well as other national and regional congresses around the world – including the IDF World Diabetes Congress. They speak at scientific sessions and symposia, engage with HCPs, researchers, policy makers and key stakeholders and report back to their communities.
Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance.
Hetero is a globally renowned, vertically integrated pharmaceutical company engaged in R&D, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Established in 1993 in Hyderabad, India, its key business areas include APIs, Global Generics, Biosimilars, and CDMO. Among the world’s largest API producers, Hetero's 29,000+ workforce spans six continents, operating 38 state-of-the-art manufacturing facilities and 60 global locations, supplying medicines to 145+ countries.
Since its establishment in 1947, LG Chem has continuously achieved growth through endless challenges and innovations as Korea’s leading chemical company. LG Chem will endeavor to become a 'Global Top 5 Chemical Company' with a balanced business portfolio that has a competitive advantage across the globe, including business divisions in petrochemicals, advanced materials, life sciences, and batteries.
Life for a Child is a program of Diabetes Australia. IDF is a partner in the work. Life for a Child supports diabetes centres caring for children and youth with diabetes in less-resourced countries. Currently over 60,000 young people are being helped in 53 countries, and we are open to potentially supporting other countries. The program’s vision is that ‘No child should die of diabetes.
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
MDE Technologies manufactures the all-new Neurometer peripheral neuropathy tester and Cardiologic autonomic neuropathy tester. We provide user-friendly, automated, portable medical devices that deliver quantifiable diagnostic data for monitoring diabetes complications. We believe that quantifiable data is one of the most useful tools available to today’s healthcare profession. We believe that user-friendly, automated, portable medical devices are the key to providing easier access to improved screening and monitoring of diabetes complications. We believe that easier access to improved screening and monitoring is the best way to help healthcare professionals provide the recommended care for their diabetic patients.
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices. The company is everywhere. In 2020 Merck generated sales of € 17.5 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics in electronics.
Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Our AI-powered screening solutions aim to transform diagnostic processes and empower early detection of various diseases, such as rapidly increasing diabetic retinopathy. Two decades of pioneering expertise, we design cutting-edge retinal imaging technology that is trusted by healthcare professionals worldwide. Our technology is extensively patented, clinically validated and has approvals in all key markets, including CE, FDA and CFDA. Optomed – Enabling Screening for All
P&G Health, the health care division of P&G company, drives consumer-centric innovation to empower our consumers to live longer, healthier, and more vibrant lives. P&G Health has partnered with the International Diabetes Federation (IDF) on multiple occasions and is committed to raise disease awareness on Diabetic Peripheral Neuropathy (DPN) among people living with diabetes. This collaboration includes global initiatives such as stand-alone satellite symposiums and research activities. By focusing on education about the symptoms and risks of DPN, P&G Health is devoted to improving the lives of individuals affected by diabetes and enhancing their understanding of Nerve Health.
Our vision at Roche Diabetes Care is to help people with diabetes think less about their daily diabetes routines. Under the brands Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery and digital solutions, we unite with partners and thought leaders around the globe to facilitate integrated personalised diabetes management (iPDM) creating patient-centred value. By building and collaborating in an open ecosystem, connecting devices, and digital solutions as well as contextualising relevant data points we drive deeper insights and innovation to enable a better understanding of the disease leading to personalised and effective therapy adjustments. For better outcomes and true relief.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Our Global Health Unit is a pioneering, not-for-profit social business model with a goal to improve the lives of underserved populations in 40 countries with the highest unmet medical needs through innovative inclusive healthcare models and partnerships, delivering a sustainable impact.
SCIARC is characterised by innovative solutions that are committed to the rapid changes in medicine at the beginning of the 21st century. The company stands for competent knowledge transfer in medicine, which is expressed in the areas of medical education - CME and webcasts as well as medical writing and consulting. We also analyse complex research results with a view to clinical benefit and build the bridge to the correct implementation of scientific findings in clinics and medical practice.
Founded to serve health, Servier is a global group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 21,900 employees of the Group are committed to this shared vocation, source of inspiration every day. Servier’ growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neurosciences and immuno-inflammatory diseases.
SOT Medical Systems is engaged in medical business for 30 years within Austria as well as internationally. In 1991 the family business started operating in the fields of angiology, phlebology and cardiology. Since 1999, a system for the fast and reliable diagnosis of pAOD patients has been self-developed: The AngETM System. Due to its modularity, it constitutes the ideal solution for angiologists, phlebologists, vascular surgeons and for the diagnosis of diabetic patients. Made in Austria Our AngE products have been developed, produced and assembled at our headquarters in Carinthia, Austria since the beginning. While doing so, we pay close attention to observe the highest quality standards and invest steadily in the research and development of our leading vascular diagnostic systems.
Founded in 1998, Yuwell Medical is a leading Chinese medical device company, listed in 2008. With 12 R&D centers and 9 global production bases, it serves 300,000 medical institutions across 131 countries, benefiting 300 million households. Specializing in respiratory therapy, diabetes management, and more, Yuwell leads in homecare and chronic disease management. Its 670,000 sq.m. manufacturing base, aligned with Industry 4.0, integrates intelligent production and digital services. Yuwell continues to innovate in medical health and life sciences.
